Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares are trading higher after the company announced the expansion of its FDA-cleared first-in-human clinical trial for cancer patients of
Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI).
New 2024 Cybersecurity and Software Regulations Required for Vehicle Sales in the European UnionCenntro Electric Group Limited (NASDAQ:CENN) ("Cenntro" or "the Company"), a leading electric vehicle technology company
President Biden Approves Psychedelics Clinical Trials For Active Military Members
President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also contains a mandate to fund clinical trials with psychedelics for active service members.